Büttner, Matthias http://orcid.org/0000-0002-7000-8257
Krogh, Dieter
Führer, Dagmar
Fuß, Carmina Teresa
Willenberg, Holger Sven
Luster, Markus
Singer, Susanne
Siggelkow, Heide
Funding for this research was provided by:
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Article History
Received: 12 December 2022
Accepted: 9 June 2023
First Online: 28 June 2023
Declarations
:
: Matthias Büttner reports speaker fees from Lilly and Takeda outside the submitted work.Dieter Krogh has nothing to disclose.Heide Siggelkow <b>Advisory boards:</b> MSD, Lilly, Amgen, Servier, Takeda, UCB, Kyowa Kirin<b>. Speaker fees:</b> MSD, Lilly, Amgen, GSK, Servier, Takeda, Alexion, Kyowa Kirin, UCB, Sandoz, Sanofi Aventis. Research support: Takeda.Susanne Singer received lecture fees from Lilly and Pfizer, all outside the submitted work.Dagmar Führer received lecture fees and honoraria for advisory boards from Eisai, Novartis, Lilly, Ipsen, MERCK, Bayer, Sanofi-Genzyme, all outside the submitted work.Carmina Teresa Fuß has nothing to disclose.Holger Sven Willenberg all support outside the submitted work—Speaker fees: Allergan, Amgen, Astra-Zeneca, Berlin-Chemie, Boeringer-Ingelheim, DEXCOM, Ipsen GmbH, Merck, Novartis, Sanofi-Genzyme, Shire / Takeda; Advisory boards: Bayer Vital GmbH, Eisei, Kyowa Kirin; Research Support: HRA pharma.Markus Luster received contracts or grants from Sanofi, Merck, Elsai and Takeda outside the submitted work.
: In accordance with the design of the study, no Ethics Committee approval was needed (confirmed by the Ethics-Committee of the Landesärztekammer Rhineland-Palatinate).
: Due to the anonymity of the survey, no individual informed consent was needed.